Antibody conjugated cyclodextrin for tumor drug delivery
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with
Tag: conjugation
A forum for researchers, students and applicants in the field of cyclodextrin technology